Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
US Biotest, Inc.
San Luis Obispo, California, United Statesusbiotest.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
US Biotest, Inc. is an active U.S.-based clinical-stage biotech/CRO focused on developing peptide-based therapeutics for indications including muscular dystrophy, diabetic ulcers, infectious diseases such as HIV and COVID‑19. The company has advanced at least one program to Phase II trials and has several preclinical assets; some programs have been discontinued.
- Therapeutic areas
- EndocrinologyNeurologyInfectious Diseases
- Modalities
- Synthetic peptidesSmall moleculesPeptide agonists/antagonists
- Industry
- Biotech
02
Partnerships
NanOlogy LLC – collaboration on certain clinical trials/programs
Beyond the preview
Go deeper on US Biotest, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on US Biotest, Inc..